Drug Profile
Cytomegalovirus vaccine live attenuated - MedImmune Vaccines
Latest Information Update: 29 Sep 2004
Price :
$50
*
At a glance
- Originator MedImmune Vaccines
- Class Cytomegalovirus vaccines; Viruses
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cytomegalovirus infections
Most Recent Events
- 29 Sep 2004 Discontinued - Phase-I for Cytomegalovirus infections treatment in USA (Injection)
- 31 Dec 2002 MedImmune has completed a phase I trial in Cytomegalovirus infections in the US
- 03 Dec 2001 This vaccine is still in active development